Document: Barr Responses To QFR’s: CLR Digs Out The Relevant Q’s & A’s
Cannabis Law Report
JANUARY 30, 2019
To expand the number of manufacturers, the Drug Enforcement Administration (DEA) submitted a notice in the Federal Register on August 11, 2016, soliciting applications for licenses to manufacture marijuana for research purposes. Both DOJ and HHS agreed to conduct a medical and scientific evaluation of CBD independent of marijuana in 2015.
63 
Let's personalize your content